Niva Bupa Health

Who are the top shareholders of the Niva Bupa Health?

The top shareholders of Niva Bupa Health are Bupa Singapore Holdings Pte Ltd with 55.98%, followed by foreign institutional investors at 8.9%, mutual funds at 2.68%, and individual investors at 4.23%. There are no pledged promoter holdings, reflecting strong promoter commitment.

The top shareholders of Niva Bupa Health include Bupa Singapore Holdings Pte Ltd, which holds a significant 55.98% of the company. The majority of the remaining shares are held by mutual funds, which account for 2.68% across 14 schemes, and foreign institutional investors (FIIs), who hold 8.9% through 42 different entities. Additionally, individual investors collectively own 4.23% of the shares. Notably, there are no pledged promoter holdings, indicating a strong commitment from the promoters.

Has Niva Bupa Health declared dividend?

No Dividend History Available

Who are the peers of the Niva Bupa Health?

Niva Bupa Health's peers include SBI Life Insurance, HDFC Life Insurance, ICICI Prudential Life, ICICI Lombard, Max Financial, and others. It has excellent growth, average management risk, and lacks a 1-year return for comparison, while HDFC Life Insurance leads with a 37.78% return.

Peers: The peers of Niva Bupa Health are Life Insurance, SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, ICICI Lombard, General Insuranc, Max Financial, Go Digit General, New India Assura, and Medi Assist Ser.<BR><BR>Quality Snapshot: Excellent management risk is observed at ICICI Lombard and Medi Assist Ser., while Average management risk is found at Life Insurance, SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, General Insuranc, Max Financial, Go Digit General, and Niva Bupa Health, and Below Average management risk is noted at New India Assura. Growth is Excellent at Niva Bupa Health and Go Digit General, Average growth is seen at SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, ICICI Lombard, General Insuranc, Max Financial, and the rest, while Below Average growth is present at Life Insurance and New India Assura. Capital Structure is Excellent across all peers.<BR><BR>Return Snapshot: The peer with the highest 1-year return is HDFC Life Insur. at 37.78%, while the peer with the lowest 1-year return is New India Assura at -22.35%. Niva Bupa Health does not have a 1-year return available for comparison. Additionally, the peers with negative six-month returns are General Insuranc, New India Assura, and Medi Assist Ser.

Is Niva Bupa Health overvalued or undervalued?

As of November 27, 2024, Niva Bupa Health is considered very expensive and overvalued, with a PE ratio of 71.14 and significant underperformance at -0.62% year-to-date compared to the Sensex's 5.54%.

As of 27 November 2024, the valuation grade for Niva Bupa Health has moved from does not qualify to very expensive. The company is currently considered overvalued, with a PE ratio of 71.14, an EV to EBITDA ratio of 263.82, and a Price to Book Value of 7.37. These metrics significantly exceed those of its peers, such as Life Insurance with a PE ratio of 12.54 and Bajaj Finance Ltd. at 35.01, indicating a stark contrast in valuation.<BR><BR>In comparison to the broader market, Niva Bupa Health has underperformed, with a year-to-date return of -0.62% against the Sensex's 5.54%. This underperformance, coupled with its high valuation ratios, reinforces the conclusion that the company is overvalued in the current market environment.

What does Niva Bupa Health do?

Niva Bupa Health Insurance Company Ltd, originally Max Bupa, is a mid-cap health insurance provider in India, reporting net sales of ₹15,274 Cr and a net profit of ₹2,061 Cr for Q1 2025. Key metrics include a P/E ratio of 78.00 and a market cap of ₹16,532 Cr.

Overview:<BR>Niva Bupa Health Insurance Company Ltd operates in the insurance industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was originally incorporated as Max Bupa Health Insurance Limited in 2008. It received its Certificate for Commencement of Business on December 23, 2008. The latest quarterly results reported are for March 2025, showcasing the company's performance in terms of sales and profit.<BR><BR>Financial Snapshot:<BR>- Net Sales: 15,274 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 2,061 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 16,532 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 78.00<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.12<BR>- Return on Equity: 10.36%<BR>- Price to Book: 7.95<BR><BR>Contact Details:<BR>No Company Details Available. Registrar Address: Not available.

How big is Niva Bupa Health?

As of 24th July, Niva Bupa Health Insurance Company Ltd has a market capitalization of 15,954.00 Cr, with recent net sales of 4,894.46 Cr and a net profit of 213.52 Cr. The company reported shareholder's funds of 2,982.58 Cr and total assets of 6,191.87 Cr for the latest annual period ending March 2024.

As of 24th July, Niva Bupa Health Insurance Company Ltd has a market capitalization of 15,954.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, Niva Bupa reported Net Sales of 4,894.46 Cr and a Net Profit of 213.52 Cr.<BR><BR>For the latest annual period ending March 2024, the company had Shareholder's Funds of 2,982.58 Cr and Total Assets amounting to 6,191.87 Cr.

How has been the historical performance of Niva Bupa Health?

Niva Bupa Health experienced significant growth from March 2024 to March 2025, with net sales rising to 4,894.46 Cr and profit after tax increasing to 213.52 Cr, while total assets grew to 9,760.16 Cr. The company improved its operating profit margin to 1.19% and enhanced cash flow from operating activities to 1,654.00 Cr.

Answer:<BR>The historical performance of Niva Bupa Health shows significant growth in various financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Niva Bupa Health's net sales increased from 3,811.25 Cr in March 2024 to 4,894.46 Cr in March 2025, while other operating income rose from 304.22 Cr to 479.82 Cr, leading to a total operating income of 5,374.28 Cr, up from 4,115.47 Cr. Total expenditure, excluding depreciation, also increased to 5,316.18 Cr from 4,254.40 Cr, with employee costs rising slightly and manufacturing expenses significantly increasing from 3,000.37 Cr to 4,061.10 Cr. The company turned around its operating profit, achieving 213.52 Cr in March 2025 compared to 81.85 Cr in March 2024, with a notable improvement in operating profit margin from -3.65% to 1.19%. Profit after tax also saw a substantial increase from 81.85 Cr to 213.52 Cr, resulting in a PAT margin growth from 2.15% to 4.36%. On the balance sheet, total assets grew from 6,191.86 Cr to 9,760.16 Cr, driven by an increase in non-current investments from 5,458.23 Cr to 8,175.08 Cr. Shareholder's funds rose significantly from 2,982.62 Cr to 3,776.22 Cr, while total liabilities increased to 9,760.16 Cr from 6,191.86 Cr. Cash flow from operating activities improved to 1,654.00 Cr from 812.00 Cr, although cash flow from investing activities worsened to -2,347.00 Cr from -1,881.00 Cr. The closing cash and cash equivalents increased to 220.00 Cr from 142.00 Cr, reflecting a positive cash flow trend.

Is Niva Bupa Health technically bullish or bearish?

As of November 28, 2025, Niva Bupa Health's technical stance is bearish due to negative indicators like a bearish MACD and moving averages, despite a mildly bullish signal from Dow Theory.

As of 28 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Niva Bupa Health is bearish, with a moderate strength. Key indicators driving this stance include the bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and moving averages on the daily timeframe, and a bearish KST on the weekly. Although the Dow Theory indicates a mildly bullish signal on the weekly, it is outweighed by the overall bearish indicators. The stock has underperformed against the Sensex year-to-date and over the past year, further supporting the bearish outlook.

When is the next results date for Niva Bupa Health Insurance Company Ltd?

The next results date for Niva Bupa Health Insurance Company Ltd is January 29, 2026.

The next results date for Niva Bupa Health Insurance Company Ltd is scheduled for January 29, 2026.

Are Niva Bupa Health Insurance Company Ltd latest results good or bad?

Niva Bupa Health Insurance Company's latest results show strong revenue growth with Q2 FY26 net sales up 17.21%, but the company reported a net loss of ₹35.27 crores and negative operating margins, raising concerns about its profitability and sustainability.

Niva Bupa Health Insurance Company Ltd's latest results present a mixed picture. On one hand, the company has shown strong revenue growth, with net sales for Q2 FY26 reaching ₹1,422.05 crores, reflecting a year-on-year increase of 17.21% and a sequential growth of 16.56%. This indicates that the company is successfully capturing market share in a growing health insurance sector.<BR><BR>However, the profitability remains a significant concern. The company reported a net loss of ₹35.27 crores for Q2 FY26, which, while reduced by 61.43% from the previous quarter, still marks the second consecutive quarterly loss in the fiscal year. This raises questions about the sustainability of its growth strategy. The operating margin also remains negative at -3.74%, although it has improved from -7.62% in the previous quarter.<BR><BR>Additionally, the return on equity (ROE) stands at a low 5.00%, which is below the industry average, indicating weak capital efficiency. The cumulative net loss for the first half of FY26 reached ₹126.71 crores, a stark contrast to the modest loss of ₹5.80 crores in the same period last year.<BR><BR>In summary, while Niva Bupa is achieving notable revenue growth, its ongoing losses and challenges in achieving profitability overshadow these positive aspects, making the overall results appear concerning.

Which are the latest news on Niva Bupa Health?

Should I buy, sell or hold Niva Bupa Health Insurance Company Ltd?

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 17-Mar, Niva Bupa Health Insurance Company's stock price is slightly rising at 71.60, despite underperforming its sector and experiencing a significant drop in investor participation. The stock has shown short-term resilience but faces long-term challenges, including disappointing quarterly results and a risky valuation.

As of 17-Mar, Niva Bupa Health Insurance Company Ltd's stock price is experiencing a slight rise, currently at 71.60, with a change of 0.14 (0.2%) upwards. This increase occurs despite the stock underperforming its sector by 0.6% today and a significant drop in investor participation, as evidenced by a 77.65% decrease in delivery volume compared to the 5-day average.<BR><BR>The stock has shown some resilience in the short term, with a 1-week return of +0.31%, while the benchmark Sensex has declined by 2.73%. However, over the longer term, the stock has faced challenges, with a 1-month decline of 6.49% and a year-to-date drop of 5.17%. Despite these setbacks, the company demonstrates strong long-term fundamental strength, highlighted by a remarkable 160.87% compound annual growth rate (CAGR) in operating profits and a healthy annual growth rate of 30.60% in net sales.<BR><BR>On the negative side, the company reported flat results for the quarter ending December 25, with a significant drop in profit after tax (PAT) of -478.5% compared to the previous four-quarter average. The negative EBITDA indicates that the stock is trading at a risky valuation compared to historical averages. Despite generating a modest return of 0.85% over the past year, the stock's profits have increased substantially, which may not be enough to offset the concerns raised by its recent financial performance.<BR><BR>In summary, while the stock is currently rising slightly, it faces significant challenges that could impact its future performance, including declining investor participation and disappointing quarterly results.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 18-Mar, Niva Bupa Health Insurance Company Ltd's stock price is declining at 71.22, with significant underperformance and a drastic drop in investor participation. The company's recent financial results show a substantial loss, indicating ongoing financial distress and contributing to the stock's downward trend.

As of 18-Mar, Niva Bupa Health Insurance Company Ltd's stock price is falling, currently at 71.22, reflecting a change of -0.28 (-0.39%). The stock has underperformed its sector by 1.74% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 71.87% compared to the 5-day average.<BR><BR>The company's recent financial performance has also raised concerns. The profit after tax for the most recent quarter was reported at Rs -87.64 crore, a drastic fall of 478.5% compared to the previous four-quarter average. Furthermore, the lowest recorded PBDIT was Rs -94.21 crore, signaling financial distress. Despite strong long-term growth in operating profits and net sales, the stock's negative EBITDA and consistent underperformance against benchmarks over the last three years contribute to its current decline. Overall, these factors indicate a challenging environment for Niva Bupa Health Insurance Company Ltd, leading to its falling stock price.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 19-Mar, Niva Bupa Health Insurance Company Ltd's stock price is declining at Rs 70.07, reflecting a -1.61% change. The stock is underperforming against benchmarks and has shown disappointing quarterly results, raising concerns about its riskiness.

As of 19-Mar, Niva Bupa Health Insurance Company Ltd is experiencing a decline in its stock price, currently at Rs 70.07, which reflects a change of -1.15 (-1.61%). The stock has been on a downward trend, having fallen for the last two days and showing a total decline of -2% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment.<BR><BR>In terms of performance relative to the benchmark, the stock has underperformed against the Sensex over various periods, including a -7.83% decline over the past month compared to a -10.05% drop in the benchmark. Despite a strong long-term growth in operating profits and net sales, recent quarterly results have been disappointing, with a significant drop in profit after tax and the lowest recorded PBDIT. This has raised concerns about the stock's riskiness, particularly given its negative EBITDA.<BR><BR>Moreover, the finance/NBFC sector has also seen a decline of -3.85%, which may be contributing to the overall negative sentiment surrounding Niva Bupa. Although there has been an increase in investor participation, with delivery volume rising by 66.39% against the 5-day average, the stock's consistent underperformance against benchmarks over the last three years and the flat results reported for December 25 have led to a cautious outlook among investors.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 20-Mar, Niva Bupa Health Insurance Company's stock is slightly rising at 69.94, but it has been underperforming over various time frames, with a year-to-date decline of 7.36%. Despite today's minor increase, the stock faces challenges from bearish trends and decreased investor participation.

As of 20-Mar, Niva Bupa Health Insurance Company Ltd's stock price is rising slightly, currently at 69.94, with a change of 0.17 (0.24%) upward. This increase can be attributed to a trend reversal, as the stock has gained after two consecutive days of decline. Additionally, it has outperformed its sector by 0.81% today, indicating a relative strength compared to its peers.<BR><BR>However, despite this short-term rise, the stock has been underperforming over various time frames. Over the past week, it has decreased by 3.21%, and over the past month, it has fallen by 9.02%. Year-to-date, the stock is down 7.36%, while it has also shown a decline of 6.60% over the past year. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the longer term.<BR><BR>Investor participation has also decreased, with a significant drop in delivery volume by 61.67% compared to the 5-day average, indicating reduced interest from investors. Despite these challenges, the company has strong long-term fundamentals, with a remarkable 160.87% CAGR growth in operating profits and a healthy annual growth rate of 30.60% in net sales. High institutional holdings at 26.36% may provide some stability, as these investors typically have better resources to analyze the company's fundamentals.<BR><BR>In summary, while the stock is experiencing a minor rise today, it faces significant headwinds from recent performance trends and declining investor participation, which could impact its future price movements.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 23-Mar, Niva Bupa Health Insurance Company's stock is at Rs 68.60, down 2.0%, and has underperformed the Sensex. Despite some positive long-term growth indicators, recent financial results show a significant decline in profit, contributing to the stock's bearish trend.

As of 23-Mar, Niva Bupa Health Insurance Company Ltd's stock price is falling, currently at Rs 68.60, reflecting a decrease of Rs 1.4 or 2.0%. The stock has underperformed the benchmark Sensex, which has also seen a decline of 3.72% over the past week. In the last month, the stock has dropped by 9.82%, while the Sensex has decreased by 12.72%. Year-to-date, Niva Bupa's stock is down 9.14%, compared to a 14.70% decline in the Sensex.<BR><BR>Today's performance indicates that the stock has outperformed its sector by 1.8%, but it reached an intraday low of Rs 68, which is a 2.86% drop. The stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Additionally, the finance/NBFC sector has fallen by 3.9%, contributing to the overall negative sentiment.<BR><BR>Despite some positive factors, such as strong long-term growth in operating profits and high institutional holdings, the recent financial results have raised concerns. The company reported a significant decline in profit after tax (PAT) for the last quarter, with a drop of 478.5% compared to the previous four-quarter average, and a negative EBITDA, which suggests that the stock is trading at risky valuations. This combination of poor recent performance and negative financial indicators is likely contributing to the stock's decline.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 24-Mar, Niva Bupa Health Insurance Company Ltd's stock price has slightly risen to 68.72, but it has significantly underperformed recently, with a 1-week decline of 3.89% and a 10.30% drop over the past month. Concerns over recent financial results and reduced investor participation contribute to a bearish outlook despite strong long-term fundamentals.

As of 24-Mar, Niva Bupa Health Insurance Company Ltd is experiencing a slight rise in its stock price, currently at 68.72, with a change of 0.12 (0.17%) upwards. However, despite this minor increase, the stock has shown a significant underperformance in the short term, with a 1-week decline of 3.89% compared to a 2.63% decline in the Sensex. Over the past month, the stock has fallen by 10.30%, while the benchmark has decreased by 9.92%.<BR><BR>Today's performance indicates that Niva Bupa Health is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock has underperformed its sector by 2.15%. A notable decline in investor participation is also evident, with delivery volume on March 23 falling by 73.98% against the 5-day average, suggesting reduced interest from investors.<BR><BR>While the company has strong long-term fundamentals, including a 160.87% CAGR growth in operating profits and a healthy annual growth rate of 30.60% in net sales, recent quarterly results have raised concerns. The company reported a PAT of Rs -87.64 crore, reflecting a drastic fall of 478.5% compared to the previous four-quarter average, and the lowest PBDIT at Rs -94.21 crore. This negative performance, coupled with a negative EBITDA, has contributed to the perception of risk associated with the stock.<BR><BR>In summary, while there is a minor uptick in the stock price, the overall trend indicates significant challenges, including poor recent financial results and declining investor participation, which are contributing to a bearish outlook for Niva Bupa Health Insurance Company Ltd.

Why is Niva Bupa Health Insurance Company Ltd falling/rising?

As of 25-Mar, Niva Bupa Health Insurance Company Ltd's stock price has risen to Rs 71.05, reflecting a 3.39% increase due to short-term gains and strong fundamentals, despite longer-term declines. The stock has shown a solid performance recently, supported by high institutional holdings, although it has faced challenges over the past month and year-to-date.

As of 25-Mar, Niva Bupa Health Insurance Company Ltd is experiencing a rise in its stock price, currently at Rs 71.05, reflecting a change of 2.33 (3.39%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 0.47% today and has been on a consecutive gain streak for the last two days, accumulating a total return of 3.57% during this period. Additionally, the stock opened with a gain of 2.14% today and reached an intraday high of Rs 73.5, marking a 6.96% increase.<BR><BR>Despite the positive performance today, it is important to note that the stock has faced challenges in the longer term. Over the past month, it has declined by 6.89%, and year-to-date, it is down by 5.89%. However, the strong long-term fundamental strength of the company, highlighted by a 160.87% compound annual growth rate (CAGR) in operating profits and a 30.60% annual growth rate in net sales, suggests a solid foundation that may support future price movements.<BR><BR>Moreover, the stock's liquidity remains adequate, with a delivery volume of 4.38 lacs, although this has fallen significantly by 75.48% compared to the 5-day average. High institutional holdings at 26.36% indicate that knowledgeable investors are backing the company, which can also contribute to positive sentiment around the stock.<BR><BR>In summary, the recent rise in Niva Bupa Health Insurance Company Ltd's stock price is primarily driven by short-term performance gains and strong underlying fundamentals, despite facing longer-term challenges and underperformance against benchmarks.